Genomics Services Market - By Service Type, By Application, By End Use – Growth Forecast, 2025 – 2034

Genomics Services Market Size

The global genomics services market size was valued at USD 8.5 billion in 2024 and is projected to grow at a CAGR of over 11.5% from 2025 to 2034. The rising prevalence of genetic disorders and growing focus on precision medicine has created an expanding market for the genomic services.
 

According to National Institutes of Health (NIH) it is estimated that 52 million genomes will be sequenced across the globe by the end of 2025. The majority of these sequences will be performed in North America and Europe, with 40.5 million genomic sequencing. This highlights the rising need for medical interventions based on an individual’s genetic profile.
 

Additionally, startups focused on genetics and growing biotech companies are helping develop next-generation sequencing technology. The industry is also benefiting from increasing investments in biotechnology research and development, along with major improvements in healthcare facilities and diagnostic technologies. Cancer genomics is one of the key growth areas in this market due to the rising cases of inherited cancer and advances in gene editing technologies like CRISPR.
 

Genomics is the study of an organism’s complete set of DNA, including all its genes and non-coding regions. Genomics services refer to a range of scientific and technological services that involve the analysis and interpretation of an individual’s genomic information. Genomics services can be used for a variety of purposes such as genetic testing, pharmacogenomics, precision medicine, and genomic research.
 

Genomics Services Market Trends

The market is experiencing rapid growth, driven by advancements in sequencing technologies, increasing adoption of personalized medicine, and rising demand for genetic testing.
 

• Next-generation sequencing (NGS) has become an essential tool in genomics research. As NGS technology leads the market, its costs have become more affordable over the years. For instance, according to National Human Genome Research Institute (NHGRI), NGS’s cost of sequencing is decreasing from USD 1 million per whole genome in 2007 to USD 200 in 2023, enabled widespread clinical and research applications.
   
• The increasing prevalence of genetic disorders has also fueled the market. According to the National Institutes of Health (NIH), a total of 7,481 patients were referred for genetic tests between 2000 and 2022. Of these 3,294 patients, including 65% males and 35% females, were diagnosed with a rare genetic disorder. These numbers highlight the need for genomic services.
   
• The increasing focus on precision and personalized medicine, especially in the field of oncology, has fueled the market. With the increase in diagnosis of inherited cancer cases, the demand for genomic services has grown. According to the National Cancer Institute, about 5%-10% of all cancers are caused by harmful genetic changes that are inherited from a parent.
   
• Furthermore, the increasing awareness and acceptance of genetic testing for various applications, such as rare diseases, are propelling market expansion. In this regard, collaborative efforts between key industry players and research institutions are driving innovation in genomics services.
   

Genomics Services Market Analysis

Based on the service type, the market is segmented into next generation sequencing, genotyping, microarray, sanger sequencing, and other services. The next generation sequencing segment dominated the market with USD 2.3 billion in 2021, USD 2.5 billion in 2022, and USD 2.7 billion in 2023.
 

• The technological advancements, declining sequencing costs, and increasing applications in research and diagnostics have increased the adoption of Next-Generation Sequencing (NGS) technology.
   
• This new technology is used for sequencing of DNA and RNA and for detection of variants/mutations within genes. NGS is rapid, and it can sequence thousands of genes or whole genomes in a very short time.
   
• The genomic services market specific for NGS technology is dominated by key leading players such as Illumina and BGI Genomics. These companies provide various sequencing platforms at an affordable cost. For example, Illumina unveiled the NovaSeq X series, which reduced the cost to USD 200 per human genome while providing results at twice the speed.
   
• NGS has become more accessible to researchers and clinicians due to the integration of cloud computing and AI-driven analytics, which enhances data processing and interpretation.
   

Based on application, the genomics services market is divided into research and diagnostics. The research segment accounted for a significant market share of 63.6% in 2024.
 

• The large share of research application segment is primarily attributed to increased focus on studying gene structures, functions, and variations. This includes genome sequencing, transcriptomics, epigenetics, and functional genomics.  These services are used by academic institutions and biotech firms for drug discovery.
   
• The increasing investments in genomic research from the pharmaceutical industry as well as governments are boosting the growth further. According to the National Human Genome Research Institute (NHGRI), the U.S. federal funding for genomics research exceeded USD 3.4 billion in 2022, showcasing its importance in healthcare and biotechnology innovation.
   
• Moreover, technological advancements in the space of CRISPR and AI-driven bioinformatics are further fueling genomic research.
   

Based on end use, the genomics services market is divided into research institutes, diagnostic centers, pharmaceutical and biotechnological companies, contract research organization (CROs), and other end users. The research institutes segment dominated the market in 2024 and is expected to reach 9.8 billion by 2034.   
 

• Research institutes are a key part of the market, playing a vital role in advancing genomic research, detecting biomarkers, and improving medical precision.
   
• Leading academic and government-supported institutions use tools like next-generation sequencing (NGS), microarrays, and bioinformatics to explore disease processes, genetic changes, and drug development opportunities.
   
• Their partnerships with biotech companies and pharmaceutical firms spark innovation, while AI-powered genomic data analysis speeds up scientific work.
   

North America: The U.S. leads the North American genomics services market and is projected to grow at 11.5% CAGR, to reach USD 9.6 billion by 2034.
 

• The high growth of the U.S. market is primarily attributed to increasing government fundings for genomic research, availability of technologically advanced research facilities, and increasing awareness and adoption of precision medicine.
   
• The government, associations, and academic institutions are taking initiatives for the improvement of genomic research. For instance, All of Us Research Program plays a key role by supporting large-scale sequencing projects aimed at advancing genomic research. The National Institutes of Health provides generous funding for these initiatives and supports other genomic research efforts as well.
   
• Furthermore, industry leaders such as Illumina are at the forefront, offering the best sequencing technologies at an affordable price. With increasing demand for cancer genome studies, pharmacogenomics, and rare disease diagnostics, these markets are expanding rapidly.   
   

Europe: The Germany genomics services market is experiencing robust growth in Europe market.  
 

• Supportive government policies, a strong biotech industry, and a well-established healthcare system of Germany provide strong backup for high growth of the genomics industry within Germany. With this, Germany stands out as one of the leading European countries in genomics.
   
• The initiatives like GenomDE, supported by the German Federal Ministry of Education and Research (BMBF), are working to better integrate genomic data into healthcare systems.
   
• Research institutions in Germany such as the Max Planck and Helmholtz Centers are focusing on advancing areas like sequencing and epigenome profiling.
   
• Germany is actively incorporating genomics into clinical care and biomedical research, which further drives the market growth.
   

Asia Pacific: The Asia Pacific genomics services market witnessed substantial growth of 11.8% during the analysis period.  China dominated the Asia Pacific market. 
 

• Government support, biotech innovations, and large genome sequencing initiatives are driving strong growth in China's genomics market.
   
• The China National GeneBank (CNGB) aims to strengthen precision medicine and become a global leader in genomics by sequencing millions of genomes.
   
• The Chinese government's 2021-2025 Strategic Priorities include funding for genetic science research, which has increased the demand for genomic testing, especially in reproductive health and oncology sequencing.
   

Latin America: The Brazil genomics services market is experiencing robust growth in Latin America market.
 

• Brazil's genomics market is steadily growing, driven by government initiatives, innovative biotechnology companies, and rising interest in genetic testing and personalized therapies.
   
• A notable example is the Genomas Brasil program, launched by the Ministry of Health, which aims to sequence 100,000 genomes to support precision medicine and public health research.
   
• Furthermore, government funding also supports market growth in the country. In 2023, the Brazilian government allocated BRL 600 million (USD 104.6 million) to the national genomic research fund, reflecting the country's strong commitment to advancing genetic sciences.
   

Middle East and Africa: The Saudi Arabia genomics services market is witnessing substantial growth in Middle East and Africa.
 

• Saudi Arabia is heavily investing in genomics to position itself as a leader in biotech and precision medicine in the Middle East. This investment shows the country's dedication to advancing genomic medicine and biotechnology.
   
• The Saudi Human Genome Program (SHGP), supported by the King Abdulaziz City for Science and Technology (KACST), is working to sequence 100,000 human genomes over the next 5 years. This effort aims to uncover insights into genetic diseases that are common in the region.
•  
• Furthermore, by partnering with international biotech companies, the government is bringing genomics into healthcare. This helps the country in focusing on rare diseases and pharmacogenomics.
   

Genomics Services Market Share

The top 5 companies in the market account for approximately 70% of the market share, with Illumina leading the industry, followed by F. Hoffmann-La Roche Ltd., BGI Genomics, Agilent Technologies, and Eurofins Scientific. These companies maintain their dominance through strategic acquisitions, advanced technology, and expanding service portfolios to meet the growing demand for genomic research and clinical applications.
 

Furthermore, to expand their market presence, key players are actively forming partnerships and collaborations with biotech firms, pharmaceutical companies, and research institutions. For example, Illumina has strengthened its leadership in clinical genomics by working with partners in oncology and hereditary disease testing. The growing demand for affordable whole-genome sequencing, direct-to-consumer (DTC) testing, and AI-powered genomic data analysis has increased competition in the market. To maintain competitive edge, companies are actively investing in research and development.
 

Genomics Services Market Companies

Major players operating in the genomics services industry are:

• 23andMe
• Agilent Technologies
• BGI Genomics
• Bio Rad Laboratories
• Color Genomics
• Danaher
• Eurofins Scientific
• F. Hoffmann-La Roche
• GE Healthcare
• GENEWIZ (Azenta)
• Illumina
• LGC
• Macrogen
• IQVIA
• QIAGEN
   
• Illumina has an extensive portfolio of next-generation sequencing (NGS) platforms for high-throughput genomic analysis. The NovaSeq X Plus system delivers ultra-high-throughput sequencing, supporting large-scale genomic studies such as population genomics and whole-genome sequencing. The company has a strong ecosystem of bioinformatics tools and software for data interpretation. Illumina's DRAGEN Bio-IT Platform accelerates secondary analysis with highly accurate and rapid variant calling.
   
• QIAGEN has comprehensive solutions for sample preparation, sequencing, and bioinformatics. The QIAseq targeted DNA panels provide end-to-end sample preparation and targeted sequencing for mutation detection.
   

Genomics Services Industry News

• In December 2024, IQVIA partnered with NVIDIA to drive AI advancements in healthcare and life sciences, focusing on accelerating drug discovery and enhancing genomic research. This collaboration strengthens IQVIA's presence in the genomics services market by leveraging AI to improve data analysis and precision medicine development.
   
• In August 2024, Eurofins acquired Orchid Cellmark, a UK-based DNA and forensic testing company, strengthening its expertise in genetic and forensic analysis. This acquisition enhances Eurofins' position in the market by expanding its capabilities in advanced DNA testing and analysis.
   
• In January 2024, Danaher launched the Danaher-IGI Beacon for CRISPR Cures in collaboration with the Innovative Genomics Institute. This initiative aims to accelerate the development of gene-editing therapies for rare diseases, strengthening Danaher's presence in the market.
   

The genomics services market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Service Type

• Next generation sequencing
• Genotyping
• Microarray
• Sanger sequencing
• Other services

Market, By Application

• Research
• Diagnostics

Market, By End Use

• Research institutes
• Diagnostic centers
• Pharmaceutical and biotechnological companies
• Contract research organization (CROs)
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE